51 related articles for article (PubMed ID: 21665183)
1. Glioblastoma specimens with TP53 mutations do not show EGFRvIII amplification.
Stoczynska-Fidelus E; Witusik-Perkowska M; Banaszczyk M; Bienkowski M; Szybka M; Piaskowski S; Cybula M; Jaskolski D; Papierz W; Liberski PP; Rieske P
Cancer Genet; 2011 May; 204(5):282-3. PubMed ID: 21665183
[No Abstract] [Full Text] [Related]
2. Selection pressures of TP53 mutation and microenvironmental location influence epidermal growth factor receptor gene amplification in human glioblastomas.
Okada Y; Hurwitz EE; Esposito JM; Brower MA; Nutt CL; Louis DN
Cancer Res; 2003 Jan; 63(2):413-6. PubMed ID: 12543796
[TBL] [Abstract][Full Text] [Related]
3. The infrequent simultaneous genetic alterations in glioblastoma multiforme (LOH 10, 17, 19q, TP53 mutation and EGFR amplification) with short clinical course.
Jesionek-Kupnicka D; Kulczycka D; Rieske P; Szybka M; Jabłońska J; Potemski P; Kolasa P; Liberski PP; Kordek R
Pol J Pathol; 2007; 58(2):79-85. PubMed ID: 17715673
[TBL] [Abstract][Full Text] [Related]
4. Magnetic resonance imaging characteristics predict epidermal growth factor receptor amplification status in glioblastoma.
Aghi M; Gaviani P; Henson JW; Batchelor TT; Louis DN; Barker FG
Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8600-5. PubMed ID: 16361543
[TBL] [Abstract][Full Text] [Related]
5. Genetic analyses for predictors of radiation response in glioblastoma.
Shih HA; Betensky RA; Dorfman MV; Louis DN; Loeffler JS; Batchelor TT
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):704-10. PubMed ID: 15978739
[TBL] [Abstract][Full Text] [Related]
6. Chromosomal instability and p53 inactivation are required for genesis of glioblastoma but not for colorectal cancer in patients with germline mismatch repair gene mutation.
Leung SY; Yuen ST; Chan TL; Chan AS; Ho JW; Kwan K; Fan YW; Hung KN; Chung LP; Wyllie AH
Oncogene; 2000 Aug; 19(35):4079-83. PubMed ID: 10962567
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of epidermal growth factor receptor in patients with glioblastoma multiforme.
Shinojima N; Tada K; Shiraishi S; Kamiryo T; Kochi M; Nakamura H; Makino K; Saya H; Hirano H; Kuratsu J; Oka K; Ishimaru Y; Ushio Y
Cancer Res; 2003 Oct; 63(20):6962-70. PubMed ID: 14583498
[TBL] [Abstract][Full Text] [Related]
8. High incidence of MGMT promoter methylation in primary glioblastomas without correlation with TP53 gene mutations.
Jesien-Lewandowicz E; Jesionek-Kupnicka D; Zawlik I; Szybka M; Kulczycka-Wojdala D; Rieske P; Sieruta M; Jaskolski D; Och W; Skowronski W; Sikorska B; Potemski P; Papierz W; Liberski PP; Kordek R
Cancer Genet Cytogenet; 2009 Jan; 188(2):77-82. PubMed ID: 19100509
[TBL] [Abstract][Full Text] [Related]
9. Diversity and frequency of epidermal growth factor receptor mutations in human glioblastomas.
Frederick L; Wang XY; Eley G; James CD
Cancer Res; 2000 Mar; 60(5):1383-7. PubMed ID: 10728703
[TBL] [Abstract][Full Text] [Related]
10. Altered expression of the suppressors PML and p53 in glioblastoma cells with the antisense-EGF-receptor.
Tian XX; Chan JY; Pang JC; Chen J; He JH; To TS; Leung SF; Ng HK
Br J Cancer; 1999 Nov; 81(6):994-1001. PubMed ID: 10576656
[TBL] [Abstract][Full Text] [Related]
11. Differential gene expression analysis reveals generation of an autocrine loop by a mutant epidermal growth factor receptor in glioma cells.
Ramnarain DB; Park S; Lee DY; Hatanpaa KJ; Scoggin SO; Otu H; Libermann TA; Raisanen JM; Ashfaq R; Wong ET; Wu J; Elliott R; Habib AA
Cancer Res; 2006 Jan; 66(2):867-74. PubMed ID: 16424019
[TBL] [Abstract][Full Text] [Related]
12. Incidence of the main genetic markers in glioblastoma multiforme is independent of tumor topology.
Necesalová E; Vranová V; Kuglík P; Cejpek P; Jarosová M; Pesáková M; Relichová J; Veselská R
Neoplasma; 2007; 54(3):212-8. PubMed ID: 17447852
[TBL] [Abstract][Full Text] [Related]
13. Selective amplification of the cytoplasmic domain of the epidermal growth factor receptor gene in glioblastoma multiforme.
Malden LT; Novak U; Kaye AH; Burgess AW
Cancer Res; 1988 May; 48(10):2711-4. PubMed ID: 2834047
[TBL] [Abstract][Full Text] [Related]
14. The EGFRvIII variant in glioblastoma multiforme.
Gan HK; Kaye AH; Luwor RB
J Clin Neurosci; 2009 Jun; 16(6):748-54. PubMed ID: 19324552
[TBL] [Abstract][Full Text] [Related]
15. TP53 codon 72 polymorphism is associated with age at onset of glioblastoma.
El Hallani S; Ducray F; Idbaih A; Marie Y; Boisselier B; Colin C; Laigle-Donadey F; Rodéro M; Chinot O; Thillet J; Hoang-Xuan K; Delattre JY; Sanson M
Neurology; 2009 Jan; 72(4):332-6. PubMed ID: 19171829
[TBL] [Abstract][Full Text] [Related]
16. Age-dependent prognostic effects of EGFR/p53 alterations in glioblastoma: study on a prospective cohort of 140 uniformly treated adult patients.
Srividya MR; Thota B; Arivazhagan A; Thennarasu K; Balasubramaniam A; Chandramouli BA; Hegde AS; Santosh V
J Clin Pathol; 2010 Aug; 63(8):687-91. PubMed ID: 20702468
[TBL] [Abstract][Full Text] [Related]
17. p53 status has no prognostic significance in glioblastomas treated with radiotherapy.
Baxendine-Jones J; Campbell I; Ellison D
Clin Neuropathol; 1997; 16(6):332-6. PubMed ID: 9401801
[TBL] [Abstract][Full Text] [Related]
18. Determination of p53 mutations, EGFR overexpression, and loss of p16 expression in pediatric glioblastomas.
Sure U; Rüedi D; Tachibana O; Yonekawa Y; Ohgaki H; Kleihues P; Hegi ME
J Neuropathol Exp Neurol; 1997 Jul; 56(7):782-9. PubMed ID: 9210874
[TBL] [Abstract][Full Text] [Related]
19. Methylation of O6-methylguanine DNA methyltransferase and loss of heterozygosity on 19q and/or 17p are overlapping features of secondary glioblastomas with prolonged survival.
Eoli M; Menghi F; Bruzzone MG; De Simone T; Valletta L; Pollo B; Bissola L; Silvani A; Bianchessi D; D'Incerti L; Filippini G; Broggi G; Boiardi A; Finocchiaro G
Clin Cancer Res; 2007 May; 13(9):2606-13. PubMed ID: 17473190
[TBL] [Abstract][Full Text] [Related]
20. Ethnicity delineates different genetic pathways in malignant glioma.
Chen P; Aldape K; Wiencke JK; Kelsey KT; Miike R; Davis RL; Liu J; Kesler-Diaz A; Takahashi M; Wrensch M
Cancer Res; 2001 May; 61(10):3949-54. PubMed ID: 11358811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
